Prescription drug · NDA
Bss (Balanced salt solution) NDC 0065-1795
Sodium chloride 6.4 mg/mL + 5 more ingredients · Solution · Ophthalmic · Alcon Laboratories, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0065-1795-04 | 0006517950400065179504 | 500 mL in 1 BAG (0065-1795-04)Marketed from Mar 28, 1969 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Bss
- Generic name (nonproprietary)
- balanced salt solution
- Active ingredients
- Sodium chloride — 6.4 mg/mLPotassium chloride — .75 mg/mLCalcium chloride — .48 mg/mLMagnesium chloride — .3 mg/mLSodium acetate — 3.9 mg/mLSodium citrate — 1.7 mg/mL
- Dosage form
- Solution
- Route
- Ophthalmic
- Labeler
- Alcon Laboratories, Inc.NDC labeler code 0065
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020742
- Marketing start
- Listing expires
- Other FDA classes
- Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
- Identifiers
- Product ID 0065-1795_e84e5d87-f672-4e37-b65b-7f6a93db552aSPL ID e84e5d87-f672-4e37-b65b-7f6a93db552aSPL set ID 28488c7b-cf6a-4a03-916f-cc66b3afdc57RxCUI 806392, 806396UNII 451W47IQ8X, 660YQ98I10, M4I0D6VV5M, 02F3473H9O, 4550K0SC9B, 1Q73Q2JULR
- Pharmacologic class
- Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400065179504followed by a unit qualifier and the quantityPackage 00065-1795-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE: For use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.
Excerpt only. Read the full label for complete information.
About NDC 0065-1795
- What is NDC 0065-1795?
- 0065-1795 is the product NDC for Bss (balanced salt solution), Sodium chloride 6.4 mg/mL + 5 more ingredients solution, listed with the FDA by Alcon Laboratories, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Bss (Balanced salt solution).
- What is the active ingredient?
- Sodium chloride, Potassium chloride, Calcium chloride, Magnesium chloride, Sodium acetate, Sodium citrate.
- Who is the labeler?
- Alcon Laboratories, Inc., NDC labeler code 0065. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Bss?
- 1 other product NDC are listed under this name. See all Bss NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Bss products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Bssbalanced salt solution | Sodium chloride 6.4 mg/mL + 5 more ingredients | SolutionOphthalmic | Alcon Laboratories, Inc. | 0065-0795 | 00065-0795-1500065-0795-50 |
Other NDCs under NDA 020742
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Bssbalanced salt solution | Sodium chloride 6.4 mg/mL + 5 more ingredients | SolutionOphthalmic | Alcon Laboratories, Inc. | 0065-0795 |